Language

Chinese English

Conference Information

Home page

Hello, "Lu Lu" – The Mascot Is Officially Named!

Jun 06,2026

"Upholding Integrity, Auspicious Fortune"

When FDA Starts "Copying" China's Homework

Jun 06,2026

FDA Eases Regulations on CGT Once Again

Legal Support and Value Empowerment for Globalization of Chinese Pharmaceutical Enterprises

Jun 06,2026

Combined with latest cases and market trends, the session delivers practical suggestions and forward-looking insights to help Chinese innovative medicines achieve high-quality global value monetization.

Peptide Drug R&D Frontier Session – Agenda Release

Jun 05,2026

we look forward to exploring the future frontiers of peptide therapeutics with you.

From Being Dropped to Rocking ASCO: The Road to Revolution's Turnaround

Jun 04,2026

Revolution dropped a bombshell.

Developing New Drugs in China: A Perspective from a Small U.S. Biotech

Jun 03,2026

How to Balance Risk and Reward?

Three Acquisitions in One Day: The Strategy Behind Eli Lilly's "Feeding Frenzy"

Jun 02,2026

The Ambition of a Trillion-Dollar Market Cap Giant

ASCO 2026: China's New Drug Army Closes in on Keytruda

Jun 01,2026

Who Is Rewriting the Future of First-Line Lung Cancer Treatment?

< 1...4 5 6...20 > proceed page

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Public Account QR Code

Registration QR Code

Conference Service Hotline

+86 010 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.